These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 22305963)

  • 1. The innate immune response to products of phospholipid peroxidation.
    Weismann D; Binder CJ
    Biochim Biophys Acta; 2012 Oct; 1818(10):2465-75. PubMed ID: 22305963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidation-specific epitopes are major targets of innate immunity in atherothrombosis.
    Bartolini Gritti B; Binder CJ
    Hamostaseologie; 2016 May; 36(2):89-96. PubMed ID: 25682990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate sensing of oxidation-specific epitopes in health and disease.
    Binder CJ; Papac-Milicevic N; Witztum JL
    Nat Rev Immunol; 2016 Aug; 16(8):485-97. PubMed ID: 27346802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity.
    Miller YI; Choi SH; Wiesner P; Fang L; Harkewicz R; Hartvigsen K; Boullier A; Gonen A; Diehl CJ; Que X; Montano E; Shaw PX; Tsimikas S; Binder CJ; Witztum JL
    Circ Res; 2011 Jan; 108(2):235-48. PubMed ID: 21252151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturally occurring IgM antibodies to oxidation-specific epitopes.
    Binder CJ
    Adv Exp Med Biol; 2012; 750():2-13. PubMed ID: 22903662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of innate immunity in atherogenesis.
    Hartvigsen K; Chou MY; Hansen LF; Shaw PX; Tsimikas S; Binder CJ; Witztum JL
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S388-93. PubMed ID: 19106070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidation-specific epitopes are important targets of innate immunity.
    Chou MY; Hartvigsen K; Hansen LF; Fogelstrand L; Shaw PX; Boullier A; Binder CJ; Witztum JL
    J Intern Med; 2008 May; 263(5):479-88. PubMed ID: 18410591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis.
    Palinski W; Witztum JL
    J Intern Med; 2000 Mar; 247(3):371-80. PubMed ID: 10762454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malondialdehyde epitopes as mediators of sterile inflammation.
    Busch CJ; Binder CJ
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Apr; 1862(4):398-406. PubMed ID: 27355566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of acrolein-specific epitopes by B cell receptors triggers an innate immune response.
    Endo R; Uchiyama K; Lim SY; Itakura M; Adachi T; Uchida K
    J Biol Chem; 2021; 296():100648. PubMed ID: 33839149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The OSE complotype and its clinical potential.
    Alic L; Binder CJ; Papac-Milicevic N
    Front Immunol; 2022; 13():1010893. PubMed ID: 36248824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipids, oxidized lipids, oxidation-specific epitopes, and Age-related Macular Degeneration.
    Handa JT; Cano M; Wang L; Datta S; Liu T
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Apr; 1862(4):430-440. PubMed ID: 27480216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural IgM antibodies against oxidation-specific epitopes.
    Binder CJ
    J Clin Immunol; 2010 May; 30 Suppl 1():S56-60. PubMed ID: 20387104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans.
    Chou MY; Fogelstrand L; Hartvigsen K; Hansen LF; Woelkers D; Shaw PX; Choi J; Perkmann T; Bäckhed F; Miller YI; Hörkkö S; Corr M; Witztum JL; Binder CJ
    J Clin Invest; 2009 May; 119(5):1335-49. PubMed ID: 19363291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role for phospholipid acyl chains and cholesterol in pulmonary infections and inflammation.
    Shaikh SR; Fessler MB; Gowdy KM
    J Leukoc Biol; 2016 Nov; 100(5):985-997. PubMed ID: 27286794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of inflammatory responses by oxidized phospholipids: structure-function relationships.
    Furnkranz A; Leitinger N
    Curr Pharm Des; 2004; 10(8):915-21. PubMed ID: 15032694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malondialdehyde Epitopes as Targets of Immunity and the Implications for Atherosclerosis.
    Papac-Milicevic N; Busch CJ; Binder CJ
    Adv Immunol; 2016; 131():1-59. PubMed ID: 27235680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox-derived damage-associated molecular patterns: Ligand function of lipid peroxidation adducts.
    Uchida K
    Redox Biol; 2013 Feb; 1(1):94-6. PubMed ID: 24024141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidation-specific epitopes as targets for biotheranostic applications in humans: biomarkers, molecular imaging and therapeutics.
    Miller YI; Tsimikas S
    Curr Opin Lipidol; 2013 Oct; 24(5):426-37. PubMed ID: 23995232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis.
    Leibundgut G; Witztum JL; Tsimikas S
    Curr Opin Pharmacol; 2013 Apr; 13(2):168-79. PubMed ID: 23541680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.